- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Key statistics
On Monday, Aethlon Medical Inc (AEMD:NAQ) closed at 1.31, 0.50% above its 52-week low of 1.30, set on May 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.36 |
---|---|
High | 1.43 |
Low | 1.31 |
Bid | 1.30 |
Offer | 1.36 |
Previous close | 1.31 |
Average volume | 8.46k |
---|---|
Shares outstanding | 2.62m |
Free float | 2.45m |
P/E (TTM) | -- |
Market cap | 3.43m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of May 06 2024 21:00 BST.
More ▼